The role of eosinophils and mast cells in intestinal functional disease. (Q37873352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

review article

1 reference

title

The role of eosinophils and mast cells in intestinal functional disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Nicholas J Talley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Marjorie M Walker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Chuin Ung

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

Current gastroenterology reports

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

323-330

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

The functional gastrointestinal disorders and the Rome III process

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Immune dysfunction in patients with functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Duodenal Implications in the Pathophysiology of Functional Dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Increased prevalence of gastrointestinal symptoms in patients with allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mast cell gastritis: children complaining of chronic abdominal pain with histologically normal gastric mucosal biopsies except for increase in mast cells, proposing a new entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Endoscopic and histological features of the large intestine in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Is irritable bowel syndrome an inflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Eosinophils and Th2 immunity: contemporary insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Gastrointestinal eosinophils in health, disease and functional disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

TLR signaling in the gut in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Type I interferon production enhances susceptibility to Listeria monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Upregulation of Toll-like Receptor (TLR) Expression and Release of Cytokines from Mast Cells by IL-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Genetic Polymorphisms of Molecules Associated with Innate Immune Responses, TRL2 and MBL2 Genes in Japanese Subjects with Functional Dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Diagnosis and management of IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-011-0197-5

Upper gastrointestinal symptoms and asthma: a manifestation of allergy?

21 January 2018

1 reference

12 December 2020

Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis

1 reference

12 December 2020

Terminal ileal mucosal mast cells in irritable bowel syndrome

1 reference

12 December 2020

Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia

1 reference

12 December 2020

Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study

1 reference

12 December 2020

A survey of dyspepsia in Great Britain

1 reference

12 December 2020

Functional gastroduodenal disorders

1 reference

12 December 2020

Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

The epidemiology of irritable bowel syndrome in North America: a systematic review

1 reference

12 December 2020

Functional GI disorders: what's in a name?

1 reference

12 December 2020

Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia

1 reference

12 December 2020

Differential expression of toll-like receptors in patients with irritable bowel syndrome.

1 reference

12 December 2020

Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia

1 reference

12 December 2020

Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning.

1 reference

12 December 2020

Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease.

1 reference

12 December 2020

Increased mast cells in the irritable bowel syndrome

1 reference

12 December 2020

Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms.

1 reference

12 December 2020

Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation

1 reference

12 December 2020

Bacterial CpG DNA activates immune cells to signal infectious danger.

1 reference

12 December 2020

10.1007/S11894-011-0197-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21552990%20AND%20SRC:MED&resulttype=core&format=json